Showing results (2951-2960 of 3,028) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|May 21, 2025
Naringin Alleviates Digoxin-induced Nephrotoxicity via Regulating Nrf2/HO-1 and PI3K/ AKT/TGF-β Cascades in Rats' Renal TissuesHoda K Said, Al Shaimaa Ibrahim Rabie, Amira S A Said, et al.Current Pharmaceutical Biotechnology|August 8, 2025
The Effects of Rukangyin on the Biological Behavior and Hippo Signaling Pathway in MDA-MB-231 Breast Cancer CellsShi Qiu, Qinyu Han, Xian Zhao, et al.Current Pharmaceutical Biotechnology|July 30, 2025
Advances in the Mechanism and Applications of Stimulus-Responsive DNA HydrogelsYifan He, Zhaohe Huang, Xiaojing Pei, et al.Current Pharmaceutical Biotechnology|October 22, 2025
Clinicopathological and Molecular Comparative Analysis of Hereditary vs. Sporadic Fumarate Hydratase-deficient Leiomyomatosis and Renal CarcinomaQi Chen, Pairidaguli Naibijiang, Yuanjing Hu, et al.Current Pharmaceutical Biotechnology|October 15, 2025
Discoidin Domain Receptor 1 in Colonic Epithelial Cells: A Paracrine Driver of Colonic FibrosisHang Gong, Xiao-Li Li, Yao-Hui Ma, et al.Current Pharmaceutical Biotechnology|October 15, 2025
Role of Major Bioactive Compounds in the Treatment of Anti-aging and Skincare: A ReviewGitishree Das, Luis Alfonso Jiménez-Ortega, Sabyasachi Banerjee, et al.Current Pharmaceutical Biotechnology|October 6, 2025
Exploring the Interplay of PI3K/AKT/mTOR and JNK Signaling Pathways in Psoriasis: Insights from Systematic Review and Network Pharmacology ApproachAli Ebrahimi, Pantea Mohammadi, Seyedeh Zahra Mirzaei, et al.Current Pharmaceutical Biotechnology|October 2, 2025
Mechanistic Insights into the Therapeutic Role of Curcumin in Leukemia: Molecular Targets and Clinical ImplicationsRajan Logesh, Waqas Alam, Khalaf F Alsharif, et al.Current Pharmaceutical Biotechnology|August 13, 2025
Critical Processes for Stability Enhancement of Phyto-ingredients: A Comprehensive ReviewEvren Algin Yapar, Merve Nur Özdemir, Thanchanok SirirakCurrent Pharmaceutical Biotechnology|August 6, 2025
Genetic Evidence for Causal Effects of Lipid-Lowering Drug Targets on Primary Sjögren's Syndrome Risk: A Mendelian Randomization StudyYuying Li, Weiquan Liao, Ying'ao Guo, et al.Pageof 303